What is the recommended cefixime (cefodoxime) dosage for treating pneumonia in adults, children, and patients with impaired renal function?

Cefpodoxime Dosing for Pneumonia

Cefpodoxime is listed as an alternative oral agent for pediatric pneumonia caused by beta-lactamase producing Haemophilus influenzae, but specific dosing is not provided in the guidelines and it is NOT a preferred agent for pneumonia treatment. 1

Pediatric Dosing (Children ≥3 months)

For Haemophilus influenzae pneumonia (beta-lactamase producing):

• Cefpodoxime is mentioned only as an alternative oral agent alongside cefdinir, cefixime, or ceftibuten 1
• No specific dose is provided in the guidelines
• The preferred oral regimen is amoxicillin-clavulanate (45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses) 1

For Streptococcus pneumoniae pneumonia:

• Cefpodoxime is listed as an alternative to amoxicillin for penicillin-susceptible strains (MIC <2.0 µg/mL) 2, 1
• Again, no specific dose is provided
• Preferred agent remains high-dose amoxicillin (90 mg/kg/day in 2 doses or 45 mg/kg/day in 3 doses) 2

Important Caveats for Pediatric Use:

• Amoxicillin is strongly preferred over cephalosporins for outpatient pneumonia treatment in fully immunized children 1
• Cefpodoxime should NOT exceed adult doses when calculated by weight 1
• The 2011 IDSA/PIDS guidelines emphasize that second- and third-generation cephalosporins like cefpodoxime are alternatives, not first-line agents

Adult Dosing

Cefpodoxime is NOT mentioned in adult pneumonia guidelines 3, 4. The 2019 ATS/IDSA adult CAP guidelines do not include cefpodoxime as a recommended agent for any severity of community-acquired pneumonia.

Standard adult regimens for CAP include:

• Outpatient: Amoxicillin 1g three times daily OR doxycycline OR a macrolide 3
• Hospitalized: Beta-lactam (ceftriaxone, cefotaxime, ampicillin) PLUS macrolide or respiratory fluoroquinolone 3

Renal Impairment

Since cefpodoxime is not a guideline-recommended agent for pneumonia and specific dosing is not provided in pneumonia guidelines, refer to cefixime renal dosing as a proxy (similar third-generation oral cephalosporin):

• CrCl ≥60 mL/min: Normal dosing
• CrCl 21-59 mL/min: Reduce dose by approximately 50%
• CrCl ≤20 mL/min or dialysis: Reduce dose by approximately 65-75% 5

Clinical Bottom Line

Do not use cefpodoxime as first-line therapy for pneumonia. The evidence strongly supports:

1. Pediatric pneumonia: Use high-dose amoxicillin (90 mg/kg/day) as first-line 1, 2
2. Adult pneumonia: Use amoxicillin, doxycycline, or macrolides for outpatient; beta-lactam plus macrolide for hospitalized 3
3. If cefpodoxime must be used (e.g., documented beta-lactamase producing H. influenzae with amoxicillin-clavulanate intolerance), extrapolate from standard cephalosporin dosing, but this is not evidence-based for pneumonia specifically

The lack of specific cefpodoxime dosing in major pneumonia guidelines reflects its limited role compared to preferred agents with superior efficacy data.